These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 8239704

  • 1. Keratinocyte gene therapy.
    Vogel JC.
    Arch Dermatol; 1993 Nov; 129(11):1478-83. PubMed ID: 8239704
    [Abstract] [Full Text] [Related]

  • 2. Cutaneous gene transfer and therapy: the present and the future.
    Spirito F, Meneguzzi G, Danos O, Mezzina M.
    J Gene Med; 2001 Nov; 3(1):21-31. PubMed ID: 11269332
    [Abstract] [Full Text] [Related]

  • 3. Gene therapy progress and prospects: the skin--easily accessible, but still far away.
    Hengge UR.
    Gene Ther; 2006 Nov; 13(22):1555-63. PubMed ID: 16957767
    [Abstract] [Full Text] [Related]

  • 4. Efficient gene transfer into human keratinocytes with recombinant adeno-associated virus vectors.
    Braun-Falco M, Doenecke A, Smola H, Hallek M.
    Gene Ther; 1999 Mar; 6(3):432-41. PubMed ID: 10435093
    [Abstract] [Full Text] [Related]

  • 5. Induction of keratinocyte proliferation and lymphocytic infiltration by in vivo introduction of the IL-6 gene into keratinocytes and possibility of keratinocyte gene therapy for inflammatory skin diseases using IL-6 mutant genes.
    Sawamura D, Meng X, Ina S, Sato M, Tamai K, Hanada K, Hashimoto I.
    J Immunol; 1998 Nov 15; 161(10):5633-9. PubMed ID: 9820543
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Sustained phenotypic reversion of junctional epidermolysis bullosa dog keratinocytes: Establishment of an immunocompetent animal model for cutaneous gene therapy.
    Spirito F, Capt A, Del Rio M, Larcher F, Guaguere E, Danos O, Meneguzzi G.
    Biochem Biophys Res Commun; 2006 Jan 20; 339(3):769-78. PubMed ID: 16316622
    [Abstract] [Full Text] [Related]

  • 12. Selectable bicistronic vectors in skin gene therapy.
    Scheidemann F, Therrien JP, Pfützner W.
    Arch Dermatol Res; 2008 Sep 20; 300(8):415-23. PubMed ID: 18663457
    [Abstract] [Full Text] [Related]

  • 13. Therapeutic plasma concentrations of human factor IX in mice after gene delivery into the amniotic cavity: a model for the prenatal treatment of haemophilia B.
    Schneider H, Adebakin S, Themis M, Cook T, Douar AM, Pavirani A, Coutelle C.
    J Gene Med; 1999 Sep 20; 1(6):424-32. PubMed ID: 10753068
    [Abstract] [Full Text] [Related]

  • 14. Evaluation of prenatal intra-amniotic LAMB3 gene delivery in a mouse model of Herlitz disease.
    Mühle C, Neuner A, Park J, Pacho F, Jiang Q, Waddington SN, Schneider H.
    Gene Ther; 2006 Dec 20; 13(23):1665-76. PubMed ID: 16871230
    [Abstract] [Full Text] [Related]

  • 15. Secretion of mouse growth hormone by transduced primary human keratinocytes: prospects for an animal model of cutaneous gene therapy.
    Peroni CN, Cecchi CR, Rosauro CW, Nonogaki S, Boccardo E, Bartolini P.
    J Gene Med; 2008 Jul 20; 10(7):734-43. PubMed ID: 18389487
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.